JenaValve Technology Inc. is engaged in design, development, manufacturing and marketing of transcatheter aortic valve replacement systems (TAVI) to treat patients with severe aortic stenosis. JenaValve is a privately-held, venture capital backed U.S. corporation with operations in Munich, Germany. The Company's TAVI products are being sold primarily in Europe. Please visit www.jenavalve.com for more information.
TypePrivate
HQMünchen, DE
Founded2006
Size (employees)60 (est)-4%
Websitejenavalve.com
JenaValve was founded in 2006 and is headquartered in München, DE
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at JenaValve

Peter Wulff

Peter Wulff

CFO
Victoria Carr-Brendel

Victoria Carr-Brendel

Ph.D., Chief Executive Officer
Mark Adler

Mark Adler

Vice President of Operations
Laura Brenton

Laura Brenton

Vice President of Clinical Affairs and International Market Development
Janet Fauls

Janet Fauls

Vice President of Quality & Regulatory
Greg Mirigian

Greg Mirigian

Vice President of R&D
Show more

JenaValve Office Locations

JenaValve has offices in München and Irvine
München, DE (HQ)
25 Guerickestraße
Show all (2)
Report incorrect company information

JenaValve Financials and Metrics

Summary Metrics

Founding Date

2006

JenaValve total Funding

$112.5 m

JenaValve latest funding size

$26.50 m

Time since last funding

3 years ago

JenaValve investors

JenaValve's latest funding round in August 2015 was reported to be $26.5 m. In total, JenaValve has raised $112.5 m
Show all financial metrics
Report incorrect company information

JenaValve Company Life and Culture

Report incorrect company information